These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26828059)

  • 1. Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration.
    Matteelli A; Lönnroth K; Mosca D; Getahun H; Centis R; D'Ambrosio L; Jaramillo E; Migliori GB; Raviglione MC
    Eur Respir J; 2016 Feb; 47(2):686-8. PubMed ID: 26828059
    [No Abstract]   [Full Text] [Related]  

  • 2. Cameroon's MDR-TB treatment programme jeopardised by cross-border migration.
    Noeske J; Foe JL; Kuaban C
    Eur Respir J; 2016 Feb; 47(2):684-6. PubMed ID: 26828058
    [No Abstract]   [Full Text] [Related]  

  • 3. End TB with precision treatment!
    van der Burgt EP; Sturkenboom MG; Bolhuis MS; Akkerman OW; Kosterink JG; de Lange WC; Cobelens FG; van der Werf TS; Alffenaar JW
    Eur Respir J; 2016 Feb; 47(2):680-2. PubMed ID: 26828056
    [No Abstract]   [Full Text] [Related]  

  • 4. Accelerating tuberculosis elimination in low-incidence settings: the role of genomics.
    Sotgiu G; Cirillo DM; Miotto P; Centis R; Migliori GB
    Eur Respir J; 2015 Dec; 46(6):1841-3. PubMed ID: 26621890
    [No Abstract]   [Full Text] [Related]  

  • 5. Accelerating tuberculosis elimination in low-incidence settings: the role of genomics.
    Guthrie JL; Gardy JL
    Eur Respir J; 2015 Dec; 46(6):1840-1. PubMed ID: 26621889
    [No Abstract]   [Full Text] [Related]  

  • 6. Towards tuberculosis elimination: an action framework for low-incidence countries.
    Lönnroth K; Migliori GB; Abubakar I; D'Ambrosio L; de Vries G; Diel R; Douglas P; Falzon D; Gaudreau MA; Goletti D; González Ochoa ER; LoBue P; Matteelli A; Njoo H; Solovic I; Story A; Tayeb T; van der Werf MJ; Weil D; Zellweger JP; Abdel Aziz M; Al Lawati MR; Aliberti S; Arrazola de Oñate W; Barreira D; Bhatia V; Blasi F; Bloom A; Bruchfeld J; Castelli F; Centis R; Chemtob D; Cirillo DM; Colorado A; Dadu A; Dahle UR; De Paoli L; Dias HM; Duarte R; Fattorini L; Gaga M; Getahun H; Glaziou P; Goguadze L; Del Granado M; Haas W; Järvinen A; Kwon GY; Mosca D; Nahid P; Nishikiori N; Noguer I; O'Donnell J; Pace-Asciak A; Pompa MG; Popescu GG; Robalo Cordeiro C; Rønning K; Ruhwald M; Sculier JP; Simunović A; Smith-Palmer A; Sotgiu G; Sulis G; Torres-Duque CA; Umeki K; Uplekar M; van Weezenbeek C; Vasankari T; Vitillo RJ; Voniatis C; Wanlin M; Raviglione MC
    Eur Respir J; 2015 Apr; 45(4):928-52. PubMed ID: 25792630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustainable tuberculosis control.
    Tannenbaum TN
    Can Respir J; 2002; 9(6):387-8. PubMed ID: 12522483
    [No Abstract]   [Full Text] [Related]  

  • 8. World tuberculosis control: how far have we to go?
    Enarson DA
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S219-23. PubMed ID: 11144556
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress towards tuberculosis control, India, 2001.
    Wkly Epidemiol Rec; 2002 Mar; 77(12):89-93. PubMed ID: 11951342
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating a global health guardian.
    Lancet Infect Dis; 2008 Jul; 8(7):401. PubMed ID: 18582829
    [No Abstract]   [Full Text] [Related]  

  • 11. DOTS in Haiti.
    Ollé-Goig JE
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):282-3. PubMed ID: 10751080
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to a major disease of poverty: the Global Partnership to Stop TB.
    Lee JW; Loevinsohn E; Kumaresan JA
    Bull World Health Organ; 2002; 80(6):428. PubMed ID: 12131996
    [No Abstract]   [Full Text] [Related]  

  • 13. The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps.
    O'Brien RJ; Nunn PP
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1055-8. PubMed ID: 11316634
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of multidrug resistance on global tuberculosis control.
    Cox H; Hargreaves S; Ismailov G
    Lancet; 2003 Nov; 362(9398):1858-9. PubMed ID: 14654338
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO's tuberculosis control strategy said to be insufficient.
    Nelson R
    Lancet Infect Dis; 2004 Nov; 4(11):653. PubMed ID: 15534937
    [No Abstract]   [Full Text] [Related]  

  • 16. Tuberculosis control goals unlikely to be met by 2005.
    Sharma DC
    Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013
    [No Abstract]   [Full Text] [Related]  

  • 17. Joining forces to develop weapons against TB: together we must.
    Freire M; Roscigno G
    Bull World Health Organ; 2002; 80(6):429. PubMed ID: 12131997
    [No Abstract]   [Full Text] [Related]  

  • 18. Carpe diem ('Seize the day'): Building on the findings of the 2015 World Health Organization evaluation of the multidrug-resistant tuberculosis (MDR-TB) programme to make the most of shortened MDR-TB treatment in South Africa.
    Loveday M; Cox H
    S Afr Med J; 2017 Feb; 107(3):176-177. PubMed ID: 28281418
    [No Abstract]   [Full Text] [Related]  

  • 19. Promoting adherence to treatment for tuberculosis: the importance of direct observation.
    Frieden TR; Sbarbaro JA
    Bull World Health Organ; 2007 May; 85(5):407-9. PubMed ID: 17639230
    [No Abstract]   [Full Text] [Related]  

  • 20. How to hinder tuberculosis control: five easy steps.
    Khan MS; Coker RJ
    Lancet; 2014 Aug; 384(9944):646-8. PubMed ID: 25064593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.